STOCK TITAN

Teladoc exec sells 7,357 shares for tax withholding

Teladoc’s U.S. Group Health president settled RSUs and PSUs into shares, then sold stock mainly to cover tax withholding from those vestings.

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Teladoc Health, Inc. (TDOC) officer Kelly Bliss, President, U.S. Group Health, reported vesting and settlement of equity awards and a related sale. On September 1, 2026, she converted 15,311 restricted and performance stock units into the same number of Teladoc common shares. On September 2, 2026, she sold 7,357 common shares at $6.301 per share, with the company stating the sale was to cover tax withholding obligations arising from the vesting of her stock unit awards. Following these transactions, she continues to hold 7,798 performance stock units directly.

Positive

  • None.

Negative

  • None.
Insider Bliss Kelly
Role President, U.S. Group Health
Sold 7,357 shs ($46K)
Approx. gross sale proceeds $46K
Type Security Shares Price Value
Sale Common Stock F3 7,357 $6.301 $46K
Exercise Restricted Stock Units F1, F4 4,859 $0.00 $0.00
Exercise Restricted Stock Units F1, F5 9,152 $0.00 $0.00
Exercise Performance Stock Units F2, F6 1,300 $0.00 $0.00
Exercise Common Stock F1 4,859 -- --
Exercise Common Stock F1 9,152 -- --
Exercise Common Stock F2 1,300 -- --
Holdings After Transaction: Restricted Stock Units — 64,636 contracts (Direct); Performance Stock Units — 7,798 contracts (Direct); Common Stock — 92,832 shares (Direct)
Footnotes (6)
  1. F1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. F2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. F3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  4. F4. On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
  5. F5. On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  6. F6. On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Common shares sold 7,357 shares Sale of Teladoc common stock on September 2, 2026
Sale price per share $6.301 per share Price for 7,357 Teladoc shares sold on September 2, 2026
RSUs converted 4,859 units Restricted stock units converted into common stock on September 1, 2026
Additional RSUs converted 9,152 units Restricted stock units converted into common stock on September 1, 2026
Performance stock units converted 1,300 units Performance stock units converted into common stock on September 1, 2026
Total stock units converted 15,311 units Total RSUs and PSUs converted into common stock on September 1, 2026
Performance stock units remaining 7,798 units Performance stock units held directly after conversion on September 1, 2026
RSUs granted March 1, 2025 109,832 units Restricted stock units granted to Kelly Bliss on March 1, 2025
Restricted stock units financial
"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Performance stock units financial
"Performance stock units convert to shares of TDOC common stock on a one-for-one basis"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
tax withholding obligation financial
"Shares sold to cover the tax withholding obligation in respect of vesting"
one-for-one basis financial
"Restricted stock units convert to shares of TDOC common stock on a one-for-one basis"

FAQ

What did Teladoc (TDOC) executive Kelly Bliss report in this Form 4?

Kelly Bliss reported the conversion of 15,311 restricted and performance stock units into Teladoc common stock on September 1, 2026, and the sale of 7,357 common shares on September 2, 2026 to address related tax withholding obligations from those vestings.

How many Teladoc (TDOC) shares did Kelly Bliss sell and at what price?

She sold 7,357 shares of Teladoc common stock on September 2, 2026 at a price of $6.301 per share. A footnote states these shares were sold to cover the tax withholding obligation tied to vesting of her restricted and performance stock unit awards.

Were the Teladoc (TDOC) shares sold by Kelly Bliss part of a Rule 10b5-1 plan?

No. The Form 4’s Rule 10b5-1 checkbox is not checked, and no footnote indicates a trading plan. The filing instead states the 7,357-share sale was executed to cover tax withholding from vesting equity awards.

How many Teladoc (TDOC) stock units did Kelly Bliss convert to common shares?

On September 1, 2026, she converted a total of 15,311 stock units into common shares: 4,859 restricted stock units, 9,152 restricted stock units, and 1,300 performance stock units, each converting on a one-for-one basis into Teladoc common stock.

What performance stock units remain outstanding for Kelly Bliss at Teladoc (TDOC)?

After converting 1,300 performance stock units into common shares on September 1, 2026, Kelly Bliss continues to hold 7,798 performance stock units directly, as reported in the Form 4’s derivative transaction table.

What prior Teladoc (TDOC) equity awards to Kelly Bliss are referenced in the Form 4?

The filing notes grants of 58,300 restricted stock units on March 19, 2024 and 109,832 restricted stock units on March 1, 2025, plus 15,596 performance stock units earned on March 1, 2026, each vesting one-third initially with the remainder in eight quarterly installments.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bliss Kelly

(Last)(First)(Middle)
C/O TELADOC HEALTH, INC.,
155 E 44TH ST, SUITE 1700

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President, U.S. Group Health
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/01/2026M4,859A(1)89,737D
Common Stock09/01/2026M9,152A(1)98,889D
Common Stock09/01/2026M1,300A(2)100,189D
Common Stock09/02/2026S7,357(3)D$6.30192,832D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(1)09/01/2026M4,859 (4) (4)Common Stock4,859$09,718D
Restricted Stock Units(1)09/01/2026M9,152 (5) (5)Common Stock9,152$054,918D
Performance Stock Units(2)09/01/2026M1,300 (6) (6)Common Stock1,300$07,798D
Explanation of Responses:
1. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
2. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
4. On March 19, 2024, the reporting person was granted 58,300 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
5. On March 1, 2025, the reporting person was granted 109,832 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
6. On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Remarks:
/s/ Adam C. Vandervoort, Attorney-in-Fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)